Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03008174
Other study ID # IRB00080981
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 5, 2016
Est. completion date December 5, 2019

Study information

Verified date January 2020
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with tracheostomy who are on and off of mechanical ventilation initially lose the ability to speak, and the use of one-way speaking valves (OWSV) is one method of restoring speech in these patients. Patients with tracheostomy who experience loss of speech report frustration and feelings of confinement from patients' communication impairment, therefore investigators would like to restore speech in these patients as soon as it is safe to do so. However, there is currently little known in the literature about the timing of the use of OWSV in patients with tracheostomy. Therefore, the investigators propose a pre-test post-test clinical trial pilot study to investigate the safety of early use of OWSV in patients undergoing a percutaneous tracheostomy. Study aims are to identify patients who would benefit from the early use of OWSV and to determine the effects of early use of OWSV on speech and clinical outcomes. To achieve these aims, patients who undergo percutaneous tracheostomy will be screened, and patients meeting screening criteria will be randomized into intervention and control groups. The intervention group will receive early speech-language pathology (SLP) evaluation and OWSV trial at 12-24 hours following tracheostomy procedure, and the control group will receive standard SLP evaluation and OWSV trial at 48-60 hours following tracheostomy procedure. Intervention and control groups will been compared on speech and clinical outcomes measures from pre-test at 12-24 hours following tracheostomy and post-test at 48-60 hours following tracheostomy and characteristics of patients who successfully tolerate early OWSV use will be identified.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 5, 2019
Est. primary completion date November 28, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient who received a percutaneous tracheostomy

- Glasgow Coma Scale score =9

- Confusion Assessment Method -ICU (CAM-ICU): negative

- Richmond Agitation Sedation Scale (RASS): -1 to +1

- Able to understand English

Exclusion Criteria:

- Open tracheostomy

- Laryngectomy

- Presently using OWSV or capped trach

- Foam-filled cuffed tracheostomy tube

- Presence of known severe airway obstruction

- Presence of post-operative bleeding requiring transfusion or packing

- Presence of air-leak around the cuff resulting in respiratory decompensation

Study Design


Intervention

Other:
Early one-way speaking valve (OWSV) assessment
The OWSV assessment by speech language pathologists will be completed at 12-24 hours following percutaneous tracheostomy procedure, which is earlier than the current standard of care of 48 hours or later.

Locations

Country Name City State
United States The Johns Hopkins Hospital Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

References & Publications (6)

Carroll SM. Silent, slow lifeworld: the communication experience of nonvocal ventilated patients. Qual Health Res. 2007 Nov;17(9):1165-77. — View Citation

Foster A. More than nothing: the lived experience of tracheostomy while acutely ill. Intensive Crit Care Nurs. 2010 Feb;26(1):33-43. doi: 10.1016/j.iccn.2009.09.004. Epub 2009 Nov 11. — View Citation

Freeman BD, Isabella K, Lin N, Buchman TG. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest. 2000 Nov;118(5):1412-8. — View Citation

Hess DR, Altobelli NP. Tracheostomy tubes. Respir Care. 2014 Jun;59(6):956-71; discussion 971-3. doi: 10.4187/respcare.02920. Review. — View Citation

Mehta AB, Syeda SN, Bajpayee L, Cooke CR, Walkey AJ, Wiener RS. Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med. 2015 Aug 15;192(4):446-54. doi: 10.1164/rccm.201502-0239OC. — View Citation

Pandian V, Thompson CB, Feller-Kopman DJ, Mirski MA. Development and validation of a quality-of-life questionnaire for mechanically ventilated ICU patients. Crit Care Med. 2015 Jan;43(1):142-8. doi: 10.1097/CCM.0000000000000552. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Speech Intelligibility as Assessed by Speech Intelligibility Test Score Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible). Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
Primary Speech Intelligibility as Assessed by Speech Intelligibility Test Score Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible). Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
Primary Speech Intelligibility as Assessed by Speech Intelligibility Test Score Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible). Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
Secondary Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores. QOL scores will be reported on a scale of 0 - 100. The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life. Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
Secondary Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores. QOL scores will be reported on a scale of 0 - 100. The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life. Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
Secondary Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores. QOL scores will be reported on a scale of 0 - 100. The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life. Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
Secondary Number of Participants With Bleeding Bleeding will be reported as present or absent. At the time of use of speaking valve up to 24hours after percutaneous tracheostomy procedure
Secondary Number of Participants With Bleeding Bleeding will be reported as present or absent. At the time of use of speaking valve between 25 and 60 hours after percutaneous tracheostomy procedure
Secondary Number of Participants With Bleeding Bleeding will be reported as present or absent. At the time of use of speaking valve between 61 hours and 21 days after percutaneous tracheostomy procedure
Secondary Intensive Care Unit (ICU) Length of Stay ICU length of stay will be reported in days. At the time of discharge, up to 4 months
Secondary Hospital Length of Stay Hospital length of stay will be reported in days. At the time of discharge, up to 4 months
See also
  Status Clinical Trial Phase
Completed NCT03909854 - Pragmatic Investigation of Volume Targeted Ventilation-1 N/A
Recruiting NCT03662438 - HOPE (Home-based Oxygen [Portable] and Exercise) for Patients on Long Term Oxygen Therapy (LTOT) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT05535543 - Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT04668313 - COVID-19 Advanced Respiratory Physiology (CARP) Study
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT03943914 - Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients. N/A
Active, not recruiting NCT03472768 - The Impact of Age-dependent Haptoglobin Deficiency on Plasma Free Hemoglobin Levels During Extracorporeal Membrane Oxygenation Support
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT02814994 - Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients N/A
Completed NCT01659268 - Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins N/A
Completed NCT01249794 - Non Invasive Ventilation After Cardiac Surgery N/A
Terminated NCT01333059 - Cycling of Sedative Infusions in Critically Ill Pediatric Patients N/A